172 related articles for article (PubMed ID: 35344627)
1. Symmetrical drug-related intertriginous and flexural exanthema-like eruption after COVID-19 vaccine.
Lahouel I; Ben Salah N; Ben Fadhel N; Chahed F; Ouni N; Belhadjali H; Aouam K; Zili J
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e597-e599. PubMed ID: 35344627
[No Abstract] [Full Text] [Related]
2. A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination.
Manaa A; Ziv M; Krausz J; Dodiuk-Gad RP
Dermatol Ther; 2022 Jul; 35(7):e15546. PubMed ID: 35485220
[No Abstract] [Full Text] [Related]
3. Reply to "A case of symmetrical drug-related intertriginous and flexural exanthema-like eruption associated with Pfizer COVID-19 vaccination" by Manaa et al.
Camela E; Scalvenzi M; Megna M; Potestio L; Guerrasio G; Fornaro L; Fabbrocini G; Costa C
Dermatol Ther; 2022 Dec; 35(12):e15881. PubMed ID: 36181410
[No Abstract] [Full Text] [Related]
4. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
[No Abstract] [Full Text] [Related]
5. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
Lim PN; Wylie G
Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
[TBL] [Abstract][Full Text] [Related]
6. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings.
Çakıcı ÖA; Güder S; Salman A; Ergun T
Indian J Dermatol Venereol Leprol; 2022; 88(6):814-816. PubMed ID: 36332096
[No Abstract] [Full Text] [Related]
7. Systemic drug-related intertriginous and flexural exanthema like eruption after CoronaVac vaccine.
Orenay OM; Balta I; Yigit D; Eksioglu M
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e634-e635. PubMed ID: 34138472
[No Abstract] [Full Text] [Related]
8. Symmetrical drug-related intertriginous and flexural exanthema-like rash related to severe acute respiratory syndrome coronavirus 2 infection.
Escolà H; March-Rodriguez A; Pujol RM
Indian J Dermatol Venereol Leprol; 2023; 89(1):119-121. PubMed ID: 36331827
[No Abstract] [Full Text] [Related]
9. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
[TBL] [Abstract][Full Text] [Related]
10. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil.
Powers R; Gordon R; Roberts K; Kovach R
Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435
[TBL] [Abstract][Full Text] [Related]
11. A case of fixed drug eruption induced by doxycycline, mimicking a symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Favrelière S; Hosteing S; Jazeron JF; Allouchery M; Lafay-Chebassier C; Perault-Pochat MC
Therapie; 2020; 75(5):511-513. PubMed ID: 31761151
[No Abstract] [Full Text] [Related]
12. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine.
Binitha MP; Sasidharanpillai S; John R; Sherjeena PV
Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589
[TBL] [Abstract][Full Text] [Related]
13. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
[TBL] [Abstract][Full Text] [Related]
14. Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Di Bona D; Miniello A; Nettis E
Clin Mol Allergy; 2022 Dec; 20(1):13. PubMed ID: 36503530
[TBL] [Abstract][Full Text] [Related]
15. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy.
Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C
Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275
[No Abstract] [Full Text] [Related]
16. A challenging case: Symmetrical drug related intertriginous and flexural exanthem, fixed drug eruption, or both?
Özkaya E; Babuna G
Pediatr Dermatol; 2011; 28(6):711-714. PubMed ID: 22082466
[TBL] [Abstract][Full Text] [Related]
17. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption.
Lyons D; Barry R; Ni Raghallaigh S
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199652
[No Abstract] [Full Text] [Related]
18. Symmetrical drug-related intertriginous and flexural exanthema due to codeine.
Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M
Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105
[No Abstract] [Full Text] [Related]
19. Symmetrical drug-related intertriginous and flexural exanthema induced by clarithromycin.
Moreira C; Cruz MJ; Cunha AP; Azevedo F
An Bras Dermatol; 2017; 92(4):587-588. PubMed ID: 28954125
[No Abstract] [Full Text] [Related]
20. Celecoxib and Bullous Symmetrical Drug-Related Intertriginous and Flexural Exanthem (SDRIFE).
Ding R; Cheo FF; Lee HY
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):629-631. PubMed ID: 36621388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
